Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,947 public trials 2,015 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, Not Recruiting

Ixazomib Maintenance Study in Patients With AL Amyloidosis

NCT03618537

Conditions
AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations
  • Tufts Medical Center Boston, Massachusetts, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
View Trial Details
Active, Not Recruiting

A Study of Combination of Selinexor, Pomalidomide, and Dexamethasone (SPd) Versus Elotuzumab, Pomalidomide, and Dexamethasone (EloPd) in Subject With Previously Treated Multiple Myeloma

NCT05028348

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • CHRU Hôtel Dieu Nantes, France
  • CHU Hôpital Saint Antoine Paris, France
  • La Pitié Paris, France
  • Klinikum Chemnitz Chemnitz, Germany
View all 20 locations
View Trial Details
Active, Not Recruiting

Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)

NCT01838512

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Local Institution Birmingham, Alabama, United States
  • Local Institute Goodyear, Arizona, United States
  • Local Institution - 0023 Anaheim, California, United States
  • Local Institution Anaheim, California, United States
View all 130 locations
View Trial Details
Active, Not Recruiting

Rituximab and Lenalidomide vs Rituximab Alone as Maintenance After R-chemoterapy for Relapsed/Refractory FL Patients

NCT02390869

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • ASST Grande Ospedale Metropolitano Niguarda Milan, MI, Italy
  • AUSL di Ravenna Ravenna, RA, Italy
  • Fondazione Del Piemonte Per L'Oncologia Ircc Di Candiolo Candiolo, Torino, Italy
  • Ospedale S. Giacomo di Castelfranco Veneto Castelfranco Veneto, Treviso, Italy
View all 28 locations
View Trial Details
Active, Not Recruiting

Ro Plus CHOEP as First Line Treatment Before HSCT in Young Patients With Nodal Peripheral T-cell Lymphomas

NCT02223208

Conditions
ALK- Anaplastic Large Cell Lymphoma (ALCL), Angioimmunoblastic T-cell Lymphoma (AITL), Hemic and Lymphatic Diseases, +15 more
Locations
  • Ospedale SS. Antonio e Biagio e Cesare Arrigo Alessandria, AL, Italy
  • Policlinico S. Orsola Malpighi Bologna, BO, Italy
  • Spedali Civili Brescia, BS, Italy
  • Ospedale Businco Cagliari, CA, Italy
View all 27 locations
View Trial Details
Active, Not Recruiting

A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma

NCT04174196

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Commack Commack, New York, United States
View Trial Details

Related conditions